Nestegg Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$419K Buy
1,651
+9
+0.5% +$2.1K 0.3% 34
2026
Q1
$401K Sell
1,642
-47
-3% -$10.9K 0.35% 34
2025
Q4
$349K Sell
1,689
-29
-2% -$5.74K 0.3% 39
2025
Q3
$319K Buy
1,718
+51
+3% +$8.74K 0.28% 36
2025
Q2
$255K Buy
1,667
+1
+0.1% +$154 0.25% 40
2025
Q1
$276K Buy
1,666
+23
+1% +$3.6K 0.29% 36
2024
Q4
$251K Buy
+1,643
New +$255K 0.25% 38

Other funds holding JNJ

Nestegg Advisors's JNJ Position: Q2 2026 in Review

Nestegg Advisors increased its Johnson & Johnson (JNJ) stake by 0.55% in Q2 2026, buying an estimated $2.1K and bringing the position to 1,651 shares worth $419K. The position accounts for 0.3% of the portfolio, ranked #34.

Nestegg Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Nestegg Advisors held 1,651 shares of Johnson & Johnson worth $419K as of Q2 2026.
  • Nestegg Advisors bought 9 Johnson & Johnson shares in Q2 2026, an estimated $2.1K.
  • Johnson & Johnson made up 0.3% of Nestegg Advisors's portfolio in Q2 2026, its #34 holding.
  • Nestegg Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nestegg Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.